drugset / Trial / NCT06213818

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participant

NCT06213818

Phase 1 Completed 137 enrolled Incyte Corporation
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is being conducted to assess the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participants.

Timeline

Start
2024-03-14
Primary completion
2025-08-19
Completion
2025-08-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule Oral
Subject Famotidine Other / unclassified Oral
Subject INCB160058 Unknown Oral

Indications

No indication recorded.